Schering-Plough
SGP
#544
Rank
A$65.62 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: A$2.91 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of A$2.91 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008A$2.91 B
2006A$2.10 B198.39%
2005A$0.70 B-395.83%
2004-A$0.24 Billion265.22%
2003-A$65.36 Million-102.01%
2002A$3.25 B3.62%
2001A$3.13 B-5.39%
2000A$3.31 B
1998A$2.73 B22.34%
1997A$2.23 B38.9%
1996A$1.61 B